JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹4.12 Cr | ₹2.98 Cr | ₹3.24 Cr | ₹3.92 Cr | ₹3.99 Cr |
What is the latest Total Non-Current Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2025 | ₹4.12 Cr |
Mar2024 | ₹2.98 Cr |
Mar2023 | ₹3.24 Cr |
Mar2022 | ₹3.92 Cr |
Mar2021 | ₹3.99 Cr |
How is Total Non-Current Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹4.12 Cr | 38.12 | |
Mar2024 | ₹2.98 Cr | -7.82 | |
Mar2023 | ₹3.24 Cr | -17.36 | |
Mar2022 | ₹3.92 Cr | -1.81 | |
Mar2021 | ₹3.99 Cr | - |
Compare Total Non-Current Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹565.0 Cr | -2.9% | -7.8% | 41.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -2.9% |
-7.8% |
41.2% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses